Abstract
This article reviews the characteristics of the main fluoroquinolones used in dentistry (ciprofloxacin, levofloxacin and moxifloxacin), including pharmacokinetic/ pharmacodynamic parameters, susceptibility profiles of oral bacteria and clinical trials on their efficacy in dental practice. It seems that some of these antibiotics might represent a safe alternative in patients with allergy, intolerance, or lack of response to beta-lactams.
Keywords: Antimicrobial susceptibility, ciprofloxacin, fluoroquinolones, focal infection, levofloxacin, moxifloxacin, oral infection, oral pathogens
Mini-Reviews in Medicinal Chemistry
Title: Efficacy of Fluoroquinolones Against Pathogenic Oral Bacteria
Volume: 9 Issue: 10
Author(s): V. Nunez Otero, J. Limeres Posse, I. Tomas Carmona and P. Diz Dios
Affiliation:
Keywords: Antimicrobial susceptibility, ciprofloxacin, fluoroquinolones, focal infection, levofloxacin, moxifloxacin, oral infection, oral pathogens
Abstract: This article reviews the characteristics of the main fluoroquinolones used in dentistry (ciprofloxacin, levofloxacin and moxifloxacin), including pharmacokinetic/ pharmacodynamic parameters, susceptibility profiles of oral bacteria and clinical trials on their efficacy in dental practice. It seems that some of these antibiotics might represent a safe alternative in patients with allergy, intolerance, or lack of response to beta-lactams.
Export Options
About this article
Cite this article as:
Otero Nunez V., Posse Limeres J., Carmona Tomas I. and Dios Diz P., Efficacy of Fluoroquinolones Against Pathogenic Oral Bacteria, Mini-Reviews in Medicinal Chemistry 2009; 9 (10) . https://dx.doi.org/10.2174/138955709789055243
DOI https://dx.doi.org/10.2174/138955709789055243 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Lysosomal Storage Diseases and the Blood-Brain Barrier
Current Pharmaceutical Design Cell Elimination as a Strategy for Repair in Acute Spinal Cord Injury
Current Pharmaceutical Design Nanotechnology in Dentistry: Drug Delivery Systems for the Control of Biofilm-Dependent Oral Diseases
Current Drug Delivery Adenosine and ATP Receptors in the Brain
Current Topics in Medicinal Chemistry The Yin and Yang of Antiviral Innate Immunity in Central Nervous System
Current Pharmaceutical Design Immunoproteasome-Selective Inhibitors: A Promising Strategy to Treat Hematologic Malignancies, Autoimmune and Inflammatory Diseases
Current Medicinal Chemistry Ubiquitin Ligases as Key Elements for the Modulation of the Immune Response: An Insight in the Pathogenesis of Autoimmunity
Current Rheumatology Reviews APO2L/TRAIL: New Insights in the Treatment of Autoimmune Disorders
Recent Patents on Inflammation & Allergy Drug Discovery Central Nervous System Manifestations in Systemic Lupus Erythematosus
Current Rheumatology Reviews Vaccination and Antiviral Treatment of Neglected Diseases Caused by Flaviviral Infections
Current Medicinal Chemistry Experimental and Clinical Advances in Immunotherapy Strategies for Spinal Cord Injury Target on MAIs and Their Receptors
Current Pharmaceutical Design Antimicrobial Development in the Era of Emerging Resistance
Mini-Reviews in Medicinal Chemistry Snake Venom Metalloproteinases: Structure, Mechanism and Induced Diseases
Current Chemical Biology Natalizumab Modifies Catecholamines Levels Present in Patients with Relapsing- Remitting Multiple Sclerosis
Current Pharmaceutical Design Mixed Connective Tissue Disease (MCTD) – A Coming of Age
Current Rheumatology Reviews Unusual Clinical Manifestations of the Antiphospholipid Syndrome
Current Rheumatology Reviews Circumventing Immune Tolerance Through Epigenetic Modification
Current Pharmaceutical Design Etiopathogenesis, Classical Immunotherapy and Innovative Nanotherapeutics for Inflammatory Neurological Disorders
Current Nanoscience Immunopathology of Brucella Infection
Recent Patents on Anti-Infective Drug Discovery Disease-Related Changes in TRPV1 Expression and Its Implications for Drug Development
Current Topics in Medicinal Chemistry